Loading company
Tempus AI, Inc.
TEM · Nasdaq · ·
Next earnings: November 3, 2026
$82.59-2.9%Sep 29 close
- 1M
- +29.0%
- 6M
- +94.9%
- 1Y
- +2.3%
TEM · Nasdaq · ·
Next earnings: November 3, 2026
$82.59-2.9%Sep 29 close
Tempus AI, Inc. is scheduled to report next on November 3, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $382.5M | $314.6M | +21.56% |
| Profit | $5.6M | -$42.8M | +113.17% |
| Profit per share | $0.03 | -$0.25 | +112.00% |
| Free Cash Flow | -$13.7M | $36.7M | -137.24% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“Through our existing collaboration with Personalis, we have already demonstrated the strength of combining highly sensitive MRD technology with our commercial infrastructure,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Tempus AI, Inc.’s Item 2.02 8-K filed July 30, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Tempus AI, Inc. has no earnings call transcript available.